BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Julphar
UBS
Merck
Baxter
Farmers Insurance
Novartis
Fish and Richardson
Colorcon
Teva

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,509,013

« Back to Dashboard

Summary for Patent: 6,509,013
Title: Method of making phosphate-binding polymers for oral administration
Abstract:Phosphate-binding polymers are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.
Inventor(s): Holmes-Farley; Stephen Randall (Arlington, MA), Mandeville, III; W. Harry (Lynnfield, MA), Whitesides; George M. (Newton, MA)
Assignee: GelTex Pharmaceuticals, Inc. (Waltham, MA)
Application Number:09/542,329
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 6,509,013

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,509,013

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2169356 ➤ Subscribe
Canada 2310960 ➤ Subscribe
Canada 2402590 ➤ Subscribe
Germany 10299003 ➤ Subscribe
Germany 69428122 ➤ Subscribe
Germany 69434726 ➤ Subscribe
Germany 122009000081 ➤ Subscribe
Denmark 0716606 ➤ Subscribe
Denmark 1133989 ➤ Subscribe
European Patent Office 0716606 ➤ Subscribe CA 2002 00003 Denmark ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Argus Health
Fuji
AstraZeneca
Deloitte
Moodys
Boehringer Ingelheim
Cipla
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot